Overview

Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma

Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of SCT-I10A for Recurrent/ Metastatic Head and Neck Squamous cell Carcinoma who progressed on or after platinum-based chemotherapy
Phase:
Phase 2
Details
Lead Sponsor:
Sinocelltech Ltd.